The MSZ diabetic male mouse represents one of the most useful tools available to researchers interested in analyzing the consequences of insulin dependent diabetes in male mice. In contrast to the high mortality induced by single high doses of SZ, protracted administration of smaller SZ dosages yields a more stable diabetic condition. Moreover, in insulitis prone strains such as BKs, the model allows synchronization: of beta cell destruction such that the inflammatory events occur on a predictable timescale. The MSZ-diabetic mouse represents a diabetic condition in which the primary etiopathologic effect is produced by an environmental toxin, and not by a genetically programmed loss of tolerance to beta cell specific antigens. In ...
The aims of this study were to evaluate in an autoimmune diabetes animal model [low-dose streptozoto...
Copyright © 2015 S. Kahraman et al. This is an open access article distributed under the Creative Co...
Loss of first-phase insulin release is an early pathogenic feature of type 2 diabetes (T2D). Various...
Abstract: The present study was designed to investigate the characteristics of diabetes mellitus ind...
1. Multiple low doses of streptozotocin (MSZ) treatment successfully induced diabetes in male TO, MF...
The murine severe combined immunodeficiency (scid) mutation was used to assess whether the diabetoge...
In a previous study, we observed that multiple low doses of streptozotocin (STZ) can induce spontane...
The aims of this study were to evaluate in an autoimmune diabetes animal model [low-dose streptozoto...
The aims of this study were to evaluate in an autoimmune diabetes animal model [low-dose streptozoto...
The aims of this study were to evaluate in an autoimmune diabetes animal model [low-dose streptozoto...
The factors associated with a diabetes-susceptible genotype in mice exhibiting various forms of heri...
Streptozotocin injection in animals destroys pancreatic beta cells, leading to insulinopenic diabete...
Although insulin-dependent diabetes mellitus (IDDM) results from irreversible loss of beta cells, th...
Human type 1 diabetes mellitus is a chronic autoimmune disease characterized by the selective loss o...
The Non-obese Diabetic Mouse (NOD) spontaneously develops diabetes with many similarities to the hum...
The aims of this study were to evaluate in an autoimmune diabetes animal model [low-dose streptozoto...
Copyright © 2015 S. Kahraman et al. This is an open access article distributed under the Creative Co...
Loss of first-phase insulin release is an early pathogenic feature of type 2 diabetes (T2D). Various...
Abstract: The present study was designed to investigate the characteristics of diabetes mellitus ind...
1. Multiple low doses of streptozotocin (MSZ) treatment successfully induced diabetes in male TO, MF...
The murine severe combined immunodeficiency (scid) mutation was used to assess whether the diabetoge...
In a previous study, we observed that multiple low doses of streptozotocin (STZ) can induce spontane...
The aims of this study were to evaluate in an autoimmune diabetes animal model [low-dose streptozoto...
The aims of this study were to evaluate in an autoimmune diabetes animal model [low-dose streptozoto...
The aims of this study were to evaluate in an autoimmune diabetes animal model [low-dose streptozoto...
The factors associated with a diabetes-susceptible genotype in mice exhibiting various forms of heri...
Streptozotocin injection in animals destroys pancreatic beta cells, leading to insulinopenic diabete...
Although insulin-dependent diabetes mellitus (IDDM) results from irreversible loss of beta cells, th...
Human type 1 diabetes mellitus is a chronic autoimmune disease characterized by the selective loss o...
The Non-obese Diabetic Mouse (NOD) spontaneously develops diabetes with many similarities to the hum...
The aims of this study were to evaluate in an autoimmune diabetes animal model [low-dose streptozoto...
Copyright © 2015 S. Kahraman et al. This is an open access article distributed under the Creative Co...
Loss of first-phase insulin release is an early pathogenic feature of type 2 diabetes (T2D). Various...